First Interim Unblinding of Pivotal AML Trial Now Imminent - Potentially the Most Important Data Moment in Company ...

(Pascal/Flickr/public domain/CC0 1.0) A specific microbe found in the human gut appears to be able to boost muscle strength, ...

A new research study showcases compelling evidence for AI-based mental health apps. Limitations exist. An AI Insider scoop.

Sporadic recreational use of magic mushrooms and LSD does not damage memory or attention, a new study finds. Instead, young adults who occasionally use classic psychedelics display a distinct ...

Clinical trial protocols lay the foundation for R&D, but they aren’t enough to ensure success. People, processes, and ...

A new paper shows that women, particularly those early in their careers, have been disproportionately affected by NIH grant ...

A long‑term study in Sarasota, Fla., details how bottlenose dolphins are social creatures that use whistles and clicks to communicate with each other.

Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics focusing on immunology and immune-oncology, ...

A UJ study in Soweto shows combining teacher guidance with computer simulations can significantly improve learners’ chemistry understanding, even in disadvantaged schools.

The new rules focus on modernizing emissions control technology used by industry. But the EPA left out Biden-era proposals for air monitors near the facility.

Arch Biopartners announces SM begins patient dosing in phase II CS-AKI trial of LSALT peptide: Toronto Monday, March 23, 2026, 18:00 Hrs [IST] Arch Biopartners Inc. (Arch) announc ...